Drug Shortage Report for ZITHROMAX - PWS ORL 100MG/5ML

Last updated on 2017-04-21 History
Report ID 1360
Drug Identification Number 02223716
Brand name ZITHROMAX - PWS ORL 100MG/5ML
Common or Proper name ZITHROMAX
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) AZITHROMYCIN
Strength(s) 100MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL
Packaging size BOTTLE/BOUTEILLE
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-01-20
Estimated end date 2017-04-21
Actual end date 2017-04-20
Shortage status Resolved
Updated date 2017-04-21
Company comments Resolved Apr 20, 2017
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2017-04-21 English Compare
v5 2017-04-20 French Compare
v4 2017-04-20 English Compare
v3 2017-03-13 French Compare
v2 2017-03-13 English Compare
v1 2017-03-13 English Compare